menu toggle

Leveraging longitudinal patient treatment patterns to determine appropriate physician education and marketing activities

By IntrinsiQ Specialty Solutions

Longitudinal treatment plans look at a patient’s history, not just that single encounter with their provider. When it comes to those specialty patients, those treatment plans are a clinical summary of both the patient’s encounters and experience.

Data in that treatment plan will show patient history, time to treatment, treatment doses and time of delivery, lab results, claims data, physician notes and those social determinants of health. While episodic data may help identify a response to treatment or an adverse event, understanding the patterns over time can help Life Sciences organizations to modify their communications with providers.

The aggregated patient data, especially when analyzed with sophisticate algorithms, provides a real- world picture of the patient journey. That picture can help a Life Sciences company tailor its communications and education to help physicians improve the management and treatment of their patients.

“Aggregated patient data provides a clear route to robust and meaningful real-world insight. The shared benefits are profound; patients get access to life-changing therapies, doctors can give their patients the best treatments possible, and life sciences companies get the evidence they need to secure regulatory approval. In an era where affordability is the primary consideration of healthcare decision-making, any data that can substantiate the use of transformative innovation is worth its weight in gold. Everyone wins.”1

During the pandemic, treatment plans involved more telehealth encounters and some delayed screenings. A recent study evaluated the changes in treatment of non–small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) during the COVID-19 pandemic and found that more than half of the patients experienced changes in their treatment plan – identifying delays in care and deferred surveillance visits.2

Life Sciences organizations can benefit from an analysis of treatment plans over the past months during the public health emergency, to ensure their education and marketing to providers is reflective of their patient’s current journey.

To learn more about longitudinal patient treatment patterns with over 20 million patient journeys mapped to date, start a conversation by reaching out to: